These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21874572)

  • 61. Patterns of oxalate metabolism in recurrent oxalate stone formers.
    Pinto B; Crespí G; Solé-Balcells F; Barceló P
    Kidney Int; 1974 Apr; 5(4):285-91. PubMed ID: 4853558
    [No Abstract]   [Full Text] [Related]  

  • 62. In vitro anti-inflammatory activity of selected oxalate-degrading probiotic bacteria: potential applications in the prevention and treatment of hyperoxaluria.
    Giardina S; Scilironi C; Michelotti A; Samuele A; Borella F; Daglia M; Marzatico F
    J Food Sci; 2014 Mar; 79(3):M384-90. PubMed ID: 24471378
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [14C]Oxalate absorption by normal persons, calcium oxalate stone formers, and patients with surgically disturbed intestinal function.
    Tiselius HG; Ahlstrand C; Lundström B; Nilsson MA
    Clin Chem; 1981 Oct; 27(10):1682-5. PubMed ID: 7285319
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of dietary oxalate and calcium on urinary oxalate and risk of formation of calcium oxalate kidney stones.
    Massey LK; Roman-Smith H; Sutton RA
    J Am Diet Assoc; 1993 Aug; 93(8):901-6. PubMed ID: 8335871
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The role of intestinal oxalate transport in hyperoxaluria and the formation of kidney stones in animals and man.
    Whittamore JM; Hatch M
    Urolithiasis; 2017 Feb; 45(1):89-108. PubMed ID: 27913853
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of an oxalate load on urinary oxalate excretion in calcium stone formers.
    de O G Mendonça C; Martini LA; Baxmann AC; Nishiura JL; Cuppari L; Sigulem DM; Heilberg IP
    J Ren Nutr; 2003 Jan; 13(1):39-46. PubMed ID: 12563622
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria?
    Hoppe B; von Unruh G; Laube N; Hesse A; Sidhu H
    Urol Res; 2005 Nov; 33(5):372-5. PubMed ID: 16284877
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Oxalate stone disease after intestinal resection.
    Gregory JG; Park KY; Schoenberg HW
    J Urol; 1977 May; 117(5):631-4. PubMed ID: 870715
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Oxalobacter formigenes and its potential role in human health.
    Duncan SH; Richardson AJ; Kaul P; Holmes RP; Allison MJ; Stewart CS
    Appl Environ Microbiol; 2002 Aug; 68(8):3841-7. PubMed ID: 12147479
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Microbial Community Transplant Results in Increased and Long-Term Oxalate Degradation.
    Miller AW; Oakeson KF; Dale C; Dearing MD
    Microb Ecol; 2016 Aug; 72(2):470-8. PubMed ID: 27312892
    [TBL] [Abstract][Full Text] [Related]  

  • 71. No contribution of ascorbic acid to renal calcium oxalate stones.
    Gerster H
    Ann Nutr Metab; 1997; 41(5):269-82. PubMed ID: 9429689
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The stomach: a new and powerful oxalate absorption site in man.
    Hautmann RE
    J Urol; 1993 Jun; 149(6):1401-4. PubMed ID: 8501776
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Different dietary calcium intake and relative supersaturation of calcium oxalate in the urine of patients forming renal stones.
    Messa P; Marangella M; Paganin L; Codardini M; Cruciatti A; Turrin D; Filiberto Z; Mioni G
    Clin Sci (Lond); 1997 Sep; 93(3):257-63. PubMed ID: 9337641
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dietary influences on urinary oxalate and risk of kidney stones.
    Massey LK
    Front Biosci; 2003 May; 8():s584-94. PubMed ID: 12700096
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of citrate on the urinary excretion of calcium and oxalate: relevance to calcium oxalate nephrolithiasis.
    Cowley DM; McWhinney BC; Brown JM; Chalmers AH
    Clin Chem; 1989 Jan; 35(1):23-8. PubMed ID: 2910576
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Oxalate status in stone-formers. Two distinct hyperoxaluric entities.
    Hatch M
    Urol Res; 1993 Jan; 21(1):55-9. PubMed ID: 8456539
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Reduced active transcellular intestinal oxalate secretion contributes to the pathogenesis of obesity-associated hyperoxaluria.
    Amin R; Asplin J; Jung D; Bashir M; Alshaikh A; Ratakonda S; Sharma S; Jeon S; Granja I; Matern D; Hassan H
    Kidney Int; 2018 May; 93(5):1098-1107. PubMed ID: 29395336
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Complex pathogenesis of hyperoxaluria after jejunoileal bypass surgery. Oxalogenic substances in diet contribute to urinary oxalate.
    Hofmann AF; Laker MF; Dharmsathaphorn K; Sherr HP; Lorenzo D
    Gastroenterology; 1983 Feb; 84(2):293-300. PubMed ID: 6848409
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Oxalobacter formigenes--characteristics and role in development of calcium oxalate urolithiasis].
    Torzewska A
    Postepy Hig Med Dosw (Online); 2013 Nov; 67():1144-53. PubMed ID: 24379255
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Understanding the gut-kidney axis in nephrolithiasis: an analysis of the gut microbiota composition and functionality of stone formers.
    Ticinesi A; Milani C; Guerra A; Allegri F; Lauretani F; Nouvenne A; Mancabelli L; Lugli GA; Turroni F; Duranti S; Mangifesta M; Viappiani A; Ferrario C; Dodi R; Dall'Asta M; Del Rio D; Ventura M; Meschi T
    Gut; 2018 Dec; 67(12):2097-2106. PubMed ID: 29705728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.